PRIOR PRINTER'S NO. 624
PRINTER'S NO. 1090
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE BILL
No.
629
Session of
2019
INTRODUCED BY RAPP, KAUFFMAN, BOROWICZ, HERSHEY, OWLETT,
ZIMMERMAN, SAYLOR, REESE, ROTHMAN, GLEIM, STRUZZI, HARKINS,
MURT, STURLA, QUINN, READSHAW, T. DAVIS, JAMES, STAATS,
PEIFER, BARRAR, McNEILL, D. MILLER, JOZWIAK, FREEMAN, BOBACK,
MACKENZIE, OTTEN, DeLUCA, CAUSER, PICKETT, LAWRENCE,
B. MILLER, GILLEN, GABLER, MASSER, ECKER, RAVENSTAHL,
HANBIDGE, MILLARD, EVERETT, EMRICK AND FRITZ,
FEBRUARY 28, 2019
AS REPORTED FROM COMMITTEE ON HEALTH, HOUSE OF REPRESENTATIVES,
AS AMENDED, MARCH 25, 2019
AN ACT
Providing for patient access to diagnostics and treatments for
Lyme disease and related tick-borne illnesses; and requiring
health care policies to provide certain coverage.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. Short title.
This act shall be known and may be cited as the Lyme Disease
and Related Tick-Borne Illness Diagnosis and Treatment Act.
Section 2. Findings.
The General Assembly finds as follows:
(1) From 2002 1990 to 2017, Pennsylvania reported 79,283
116,824 confirmed cases of Lyme disease and in 2017 reported
10,001 11,900 new cases, ranking highest in the nation in
confirmed cases for the last seven years. BECAUSE THE UNITED
STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR
<--
<--
<--
<--
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15